STOCK TITAN

BioMarin to Participate in Two Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) announced its participation in two upcoming virtual investor conferences. An audio webcast of the presentations will be available for live access and later archived on the company's website. BioMarin focuses on developing innovative therapies for life-threatening rare disorders, boasting a portfolio that includes six commercialized products along with several clinical and pre-clinical candidates. For further details, please visit www.biomarin.com.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., Dec. 1, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. 

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors                              

Media

Traci McCarty                                      

Debra Charlesworth

BioMarin Pharmaceutical Inc.                    

BioMarin Pharmaceutical Inc.

(415) 455-7558                                               

(415) 455-7451

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301182457.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin's upcoming virtual investor conference?

BioMarin will participate in two virtual investor conferences, but specific dates are not mentioned in the press release.

How can I access the live webcast of BioMarin's presentations?

You can access the live audio webcast of BioMarin's presentations on their investors' website at https://investors.biomarin.com.

What does BioMarin specialize in?

BioMarin specializes in developing innovative therapies for serious and life-threatening rare disorders.

What products does BioMarin currently offer?

BioMarin has a portfolio of six commercialized products along with multiple clinical and pre-clinical candidates.

Where can I find more information about BioMarin?

More information about BioMarin can be found on their official website at www.biomarin.com.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

12.46B
188.90M
0.87%
97.78%
2.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO